Key result
Type 2 diabetes in breast cancer survivors was associated with significantly higher odds of infection (OR 1.86) and anemia (OR 1.43), as well as increased outpatient resource utilization.
Why the study?
Up to 74% of breast cancer survivors have at least one preexisting comorbid condition, with type 2 diabetes being common, but differences in health-related outcomes and healthcare resource utilization remained to be examined.
Does preexisting type 2 diabetes increase adverse health-related outcomes and healthcare resource utilization in breast cancer survivors?
Cohort (n=6,851)
Yes
Does preexisting type 2 diabetes increase adverse health-related outcomes and healthcare resource utilization in breast cancer survivors?
Odds Ratio: 1.86 (95% CI 1.35–2.55)
Type 2 diabetes in breast cancer survivors is associated with increased odds of anemia, infection, and higher outpatient healthcare resource utilization.
PURPOSE: Up to 74% of breast cancer survivors (BCS) have at least one preexisting comorbid condition, with diabetes (type 2) common. The purpose of this study was to examine differences in health-related outcomes (anemia, neutropenia, and infection) and utilization of health care resources (inpatient, outpatient, and emergency visits) in BCS with and without diabetes. METHODS: In this retrospective cohort study, data were leveraged from the electronic health records of a large health network linked to the Indiana State Cancer Registry. BCS diagnosed between January 2007 and December 2017 and who had received chemotherapy were included. Multivariable logistic regression and generalized linear models were used to determine differences in health outcomes and health care resources. RESULTS: The cohort included 6851 BCS, of whom 1121 (16%) had a diagnosis of diabetes. BCS were, on average, 55 (standard deviation: 11.88) years old, the majority self-reported race as White (90%), and 48.8% had stage II breast cancer. BCS with diabetes were significantly older (mean age of 60.6 [SD: 10.34] years) than those without diabetes and were often obese (66% had body mass index of ≥33). BCS with diabetes had higher odds of anemia (odds ratio: 1.43; 95% CI: 1.04, 1.96) and infection (odds ratio: 1.86; 95% CI: 1.35, 2.55) and utilized more outpatient resources (P<0.0001). CONCLUSIONS: Diabetes has a deleterious effect on health-related outcomes and health care resource utilization among BCS. These findings support the need for clinical practice guidelines to help clinicians manage diabetes among BCS throughout the cancer trajectory and for coordinated models of care to reduce high resource utilization.
No takes yet. Share an insight, caveat, or question.
Storey et al. (2022) conducted a cohort in Breast Cancer (n=6,851). Type 2 diabetes vs. Without type 2 diabetes was evaluated on Infection within 1 year following the start of chemotherapy (OR 1.86, 95% CI 1.35-2.55). Type 2 diabetes in breast cancer survivors was associated with significantly higher odds of infection (OR 1.86) and anemia (OR 1.43), as well as increased outpatient resource utilization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: